Invivyd, INC Form 4 insider transactions

Jill Andersen, Chief Legal Officer and Secretary of Invivyd, Inc., reports the acquisition of stock options and restricted stock units.

Chief Financial Officer William E. Duke of Invivyd, Inc. reports the acquisition of stock options and restricted stock units.

Robert D. Allen III, Chief Scientific Officer of Invivyd, Inc., reports the acquisition of stock options and restricted stock units.

Julie Green, Chief Human Resources Officer of Invivyd, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in the company.

Chief Commercial Officer Timothy Edward Lee reports the acquisition of stock options and restricted stock units in Invivyd, Inc.

Invivyd director Terrance McGuire sold a total of 273,763 shares of common stock across three days in late December 2024, at weighted average prices ranging from $0.4455 to $0.5212.

Terrance McGuire, a director at Invivyd, Inc., sold a total of 347,559 shares of common stock across multiple transactions between December 20th and December 26th, 2024.

Invivyd director Terrance McGuire sold a total of 324,241 shares of common stock across three days, with prices ranging from $0.4281 to $0.5055.

Invivyd director Terrance McGuire sold a total of 190,359 shares of common stock in two separate transactions on December 12th and 16th, 2024.

Terrance McGuire, a director at Invivyd, Inc., sold a total of 485,400 shares of common stock across three days in December 2024.

Chief Commercial Officer Timothy Edward Lee of Invivyd, Inc. was granted stock options to purchase 600,000 shares of common stock.

Terrance McGuire, a director of Invivyd, Inc., sold 112,381 shares of common stock at an average price of $1.6602 on May 29, 2024.

Terrance McGuire, a director of Invivyd, Inc., acquired stock options for 50,000 shares on May 21, 2024.

Director Sara Cotter acquired stock options in Invivyd, Inc. on May 21, 2024.

Director Kevin F. McLaughlin acquired 100,000 stock options in Invivyd, Inc. on May 21, 2024.

Director Tamsin Berry acquired stock options in Invivyd, Inc. on May 21, 2024.

Marc Elia, a director of Invivyd, Inc., was granted a stock option for 50,000 shares, vesting in full by May 21, 2025, or the date of the 2025 Annual Meeting of Stockholders.

Christine Lindenboom, a director at Invivyd, Inc., acquired 50,000 stock options on May 21, 2024, as reported in a Form 4 filing with the SEC.

Director Srishti Gupta reports the acquisition of stock options in Invivyd, Inc.